These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19960459)

  • 21. Grape seed proanthocyanidins repress the hepatic lipid regulators miR-33 and miR-122 in rats.
    Baselga-Escudero L; Bladé C; Ribas-Latre A; Casanova E; Salvadó MJ; Arola L; Arola-Arnal A
    Mol Nutr Food Res; 2012 Nov; 56(11):1636-46. PubMed ID: 22965541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of proanthocyanidins on blood lipids: A systematic review and meta-analysis.
    Wang P; Liu XL; Jiang ZZ; Long Y; Gao CL; Huang W; Tan XZ; Ma XM; Xu Y
    Phytother Res; 2024 May; 38(5):2154-2164. PubMed ID: 38391003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic supplementation of proanthocyanidins reduces postprandial lipemia and liver miR-33a and miR-122 levels in a dose-dependent manner in healthy rats.
    Baselga-Escudero L; Blade C; Ribas-Latre A; Casanova E; Salvadó MJ; Arola L; Arola-Arnal A
    J Nutr Biochem; 2014 Feb; 25(2):151-6. PubMed ID: 24445039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk.
    Warnakula S; Hsieh J; Adeli K; Hussain MM; Tso P; Proctor SD
    Can J Cardiol; 2011; 27(2):183-91. PubMed ID: 21459267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of polyphenols from peanut skin extract associated with plasma lipid lowering function.
    Bansode RR; Randolph P; Ahmedna M; Hurley S; Hanner T; Baxter SA; Johnston TA; Su M; Holmes BM; Yu J; Williams LL
    Food Chem; 2014 Apr; 148():24-9. PubMed ID: 24262521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dietary carbohydrate restriction with and without weight loss on atherogenic dyslipidemia.
    Wood RJ
    Nutr Rev; 2006 Dec; 64(12):539-45. PubMed ID: 17274496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthy properties of proanthocyanidins.
    de la Iglesia R; Milagro FI; Campión J; Boqué N; Martínez JA
    Biofactors; 2010; 36(3):159-68. PubMed ID: 20232344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies.
    Feldman F; Koudoufio M; Desjardins Y; Spahis S; Delvin E; Levy E
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol and chloroquine.
    Borba EF
    Rev Bras Reumatol; 2011 Dec; 51(6):673. PubMed ID: 22124601
    [No Abstract]   [Full Text] [Related]  

  • 30. Proanthocyanidins of Natural Origin: Molecular Mechanisms and Implications for Lipid Disorder and Aging-Associated Diseases.
    Nie Y; Stürzenbaum SR
    Adv Nutr; 2019 May; 10(3):464-478. PubMed ID: 30926997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Tiaoqiheying decoction in the treatment of spasmodic pain and lipid metabolism after acute ischemic stroke.
    Cai Z; Chen Y
    J Int Med Res; 2020 Jan; 48(1):300060519894079. PubMed ID: 31948302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proanthocyanidins in health care: current and new trends.
    Cos P; De Bruyne T; Hermans N; Apers S; Berghe DV; Vlietinck AJ
    Curr Med Chem; 2004 May; 11(10):1345-59. PubMed ID: 15134524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposed mechanisms of the effects of proanthocyanidins on glucose homeostasis.
    Yang K; Chan CB
    Nutr Rev; 2017 Aug; 75(8):642-657. PubMed ID: 28969360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of lipid disorders in nephrotic syndrome.
    Vaziri ND
    Kidney Int; 2003 May; 63(5):1964-76. PubMed ID: 12675893
    [No Abstract]   [Full Text] [Related]  

  • 35. Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder.
    Wang TK; Xu S; Li S; Zhang Y
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of flavanol and procyanidin intake to influence age-related vascular disease.
    Holt RR; Heiss C; Kelm M; Keen CL
    J Nutr Gerontol Geriatr; 2012; 31(3):290-323. PubMed ID: 22888843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid metabolism.
    Pavlic M; Lewis GF
    Curr Opin Lipidol; 2011 Oct; 22(5):433-6. PubMed ID: 21904126
    [No Abstract]   [Full Text] [Related]  

  • 38. Proanthocyanidins in health and disease.
    Bladé C; Aragonès G; Arola-Arnal A; Muguerza B; Bravo FI; Salvadó MJ; Arola L; Suárez M
    Biofactors; 2016; 42(1):5-12. PubMed ID: 26762288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proanthocyanidins: oligomeric structures with unique biochemical properties and great therapeutic promise.
    Xu Z; Du P; Meiser P; Jacob C
    Nat Prod Commun; 2012 Mar; 7(3):381-8. PubMed ID: 22545414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of proanthocyanidin rich extracts in obesity.
    Salvadó MJ; Casanova E; Fernández-Iglesias A; Arola L; Bladé C
    Food Funct; 2015 Apr; 6(4):1053-71. PubMed ID: 25669490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.